Ghost Tree Capital »

Tenaya Therapeutics shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.2M 1.4M 3.10
2024-03-31 $4.1M 775k 5.23

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Tenaya Therapeutics

Column Group
RA Capital Management
Casdin Capital
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Octagon Capital Advisors
Citadel Advisors
VR Adviser
Ghost Tree Capital
Geode Capital Management
State Street Corporation
Euclidean Capital
Schonfeld Strategic Advisors

View all funds holding Tenaya Therapeutics